Pre-existing antiacetylcholine receptor autoantibodies and B cell lymphopaenia are associated with the development of myositis in patients with thymoma treated with avelumab, an immune checkpoint inhibitor targeting programmed death-ligand 1.

ABSTRACT:

SUBMITTER: Mammen AL 

PROVIDER: S-EPMC6447048 | biostudies-literature | 2019 Jan

REPOSITORIES: biostudies-literature